Three types of nasal sprays recalled over ‘superpotency’ concerns
The FDA says the man-made hormone could cause seizures, coma, or death
(The Associated Press) FILE – (AP Photo/Jacquelyn Martin)
(The Associated Press) FILE - This Aug. 2, 2018 file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. The FDA announced plans Monday, Feb. 11, 2019, to step up its policing of dietary supplements, which it said has mushroomed into a $40 billion industry with more than 50,000 products. (AP Photo/Jacquelyn Martin)
Columbia, SC (WOLO) — The Food and Drug Administration (FDA) is recalling three forms of nasal spray they say could have too much of a man-made hormone.
Ferring Pharmaceuticals, the maker of the sprays decided to pull after the impacted products after discovering “superpotency or amounts of desmopressin higher than specified,”.
The FDA released a notice Wednesday where they say the findings were the result of routine testing. According to the agency, the problem with too much of this hormone desmopressin is that it involved abnormally low levels of sodium in the blood the agency says could cause seizures, coma or even death.
The recalled sprays include DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL and Stimate Nasal Spray 1.5 mg/mL.
For a full review of the effected items batch numbers and expiration dates are listed here.
